-+ 0.00%
-+ 0.00%
-+ 0.00%

Stifel Maintains Buy on Disc Medicine, Lowers Price Target to $110

Benzinga·02/17/2026 16:49:18
Listen to the news
Stifel analyst Stephen Willey maintains Disc Medicine (NASDAQ:IRON) with a Buy and lowers the price target from $125 to $110.